AXGN Q3 2023 Earnings — AxoGen, Inc. Revenue & Financial Results | Market Cap Arena

AXGNAxoGen, Inc.

$2B

Q3 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$41M+11.7% YoY

Gross Profit

$32M76.8% margin

Operating Income

-$4M-9.8% margin

Net Income

-$4M-9.9% margin

EPS (Diluted)

$-0.10

QoQ Revenue Growth

+8.2%

Cash Flow

Operating Cash Flow

$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$195M

Total Liabilities

$97M

Stockholders' Equity

$98M

Cash & Equivalents

$37M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$41M	$37M	+11.7%
Gross Profit	$32M	$31M	+3.0%
Operating Income	-$4M	-$5M	+17.1%
Net Income	-$4M	-$4M	+5.3%